The investigations target a series of high-profile corporate shifts. Pulmatrix, Inc. (NASDAQ: PULM) is under review regarding its merger with Eos SENOLYTIX, Inc., a deal that would leave current Pulmatrix shareholders with approximately 6% of the combined entity. Simultaneously, the firm is examining the sale of Simulations Plus, Inc. (NASDAQ: SLP) to affiliates of Altaris, LLC, which offers shareholders a cash payout of $18.50 per share.

The firm is also focusing on the consolidation between Olin Corporation (NYSE: OLN) and Huntsman Corporation (NYSE: HUN). In this transaction, Olin shareholders are slated to own 54.5% of the resulting company, while Huntsman shareholders are set to receive 0.5476 shares of Olin for each share held. With a shareholder vote for the Olin-Huntsman deal scheduled for August 25, 2026, Monteverde & Associates is urging investors to evaluate their positions. Those interested in the inquiries can contact the firm at (212) 971-1341 or visit their website.